Tobacco harm reduction in people with serious mental illnesses

The Lancet Psychiatry

Volumn 2, Issue 6, 2015, Pages 485-487

  Gartner, Coral ^a   Hall, Wayne ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; VARENICLINE; NICOTINE GUM;

ANXIETY; CANCER RISK; DEPRESSION; ELECTRONIC CIGARETTE; HARM REDUCTION; HUMAN; ISCHEMIC HEART DISEASE; MENTAL DISEASE; NEGATIVE SYNDROME; NICOTINE REPLACEMENT THERAPY; NOTE; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SMOKING; SMOKING BAN; SMOKING CESSATION; ADVERSE EFFECTS; EPIDEMIOLOGY; PROCEDURES; PSYCHOLOGY; TOBACCO;

HARM REDUCTION; HUMANS; MENTAL DISORDERS; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO USE CESSATION PRODUCTS;

EID: 84930074400     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00238-2     Document Type: Note

References (15)

1. Ruther T, Bobes J, De Hert M, et al. EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry 2014, 29:65-82.
2. Smith PH, Mazure CM, McKee SA Smoking and mental illness in the US population. Tob Control 2014, published online April 17. http://dx.doi.org/10.1136/tobaccocontrol-2013-051466.
3. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014, 348:g1151.
4. Ziedonis D, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 2008, 10:1691-1715.
5. Parker C, McNeill A, Ratschen E Tailored tobacco dependence support for mental health patients: a model for inpatient and community services. Addiction 2012, 107(suppl 2):18-25.
6. Prochaska JJ Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?. Drug Alcohol Depend 2010, 110:177-182.
7. Tobacco: harm-reduction approaches to smoking National Institute for Health and Care Excellence, (accessed March 1, 2014). http://guidance.nice.org.uk/PH45.
8. Tsoi DT, Porwal M, Webster AC Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2013, 2. CD007253.
9. Banham L, Gilbody S Smoking cessation in severe mental illness: what works?. Addiction 2010, 105:1176-1189.
10. Winterer G Why do patients with schizophrenia smoke?. Curr Opin Psychiatry 2010, 23:112-119.
11. Kelly DL, McMahon RP, Wehring HJ, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull 2011, 37:832-838.
12. Hughes JR Dependence potential and abuse liability of nicotine replacement therapies. Biomed Pharmacother 1989, 43:11-17.
13. Foulds J, Ramstrom L, Burke M, Fagerstrom K Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003, 12:349-359.
14. McNeill A, Munafo MR Reducing harm from tobacco use. J Psychopharmacol 2013, 27:13-18.
15. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 2013, 10:446-461.